BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 376141)

  • 21. Serum Soluble CD48 Levels as a Prognostic Marker in Mycosis Fungoides and Sézary Syndrome.
    Oka T; Miyagaki T; Takahashi N; Nakajima R; Kamijo H; Suga H; Asano Y; Sugaya M; Sato S
    J Invest Dermatol; 2018 Oct; 138(10):2286-2288. PubMed ID: 29605670
    [No Abstract]   [Full Text] [Related]  

  • 22. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cutaneous malignant lymphomas].
    Ben Romdhane K
    Tunis Med; 1989; 67(6-7):385-90. PubMed ID: 2678641
    [No Abstract]   [Full Text] [Related]  

  • 24. Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides.
    Tosca A; Linardopoulos S; Malliri A; Hatziolou E; Nicolaidou A; Spandidos DA
    Anticancer Res; 1991; 11(4):1433-8. PubMed ID: 1746900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD30
    Ellis A; Christensen LF; Sharma T; Meyerson H; Kord H; Cooper KD
    J Am Acad Dermatol; 2021 Feb; 84(2):530-532. PubMed ID: 32437721
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
    Thivolet J; Schmitt D; Souteyrand P; Brochier J
    Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycosis fungoides.
    Gaeke ME; Variakojis D; Sweet DL
    Curr Probl Cancer; 1981 Sep; 6(3):1-39. PubMed ID: 7285618
    [No Abstract]   [Full Text] [Related]  

  • 28. Biopsy correlation of surface area vs. single-axis measurements on computed tomography scan of lymph nodes in patients with erythrodermic mycosis fungoides and Sézary syndrome.
    Haththotuwa R; Zilinskiene L; Oliff J; Vydianath B; Amel-Kashipaz R; Stevens A; Shah F; Chaganti S; Scarisbrick J
    Br J Dermatol; 2017 Sep; 177(3):877-878. PubMed ID: 28012157
    [No Abstract]   [Full Text] [Related]  

  • 29. Lymph node histopathology in mycosis fungoides and Sézary's syndrome.
    Scheffer E; Meijer CJ; Willemze R; van Vloten WA
    Curr Probl Dermatol; 1990; 19():105-13. PubMed ID: 2404671
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis of malignant cutaneous lymphomas].
    Sterry W
    Dtsch Med Wochenschr; 1988 Feb; 113(5):184-9. PubMed ID: 3276493
    [No Abstract]   [Full Text] [Related]  

  • 31. TIGIT and Helios Are Highly Expressed on CD4
    Jariwala N; Benoit B; Kossenkov AV; Oetjen LK; Whelan TM; Cornejo CM; Takeshita J; Kim BS; Showe LC; Wysocka M; Rook AH
    J Invest Dermatol; 2017 Jan; 137(1):257-260. PubMed ID: 27592800
    [No Abstract]   [Full Text] [Related]  

  • 32. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders.
    Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome).
    Galindo LM; Garcia FU; Hanau CA; Lessin SR; Jhala N; Bigler RD; Vonderheid EC
    Am J Clin Pathol; 2000 Jun; 113(6):865-71. PubMed ID: 10874888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sézary syndrome.
    Davis MD; Alonsollamazares J; McEvoy MT
    Eur J Dermatol; 2007; 17(1):96. PubMed ID: 17324842
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome.
    Willemze R; Scheffer E; Meijer CJ
    Am J Pathol; 1985 Jul; 120(1):46-54. PubMed ID: 3893151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal Langerhans cells in mycosis fungoides and Sézary syndrome.
    Matejka M; Konrad K
    Wien Klin Wochenschr; 1983 Dec; 95(23):847-52. PubMed ID: 6670281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sézary cells in ascitic fluid.
    Vernon SE; Rosenthal DL
    Acta Cytol; 1979; 23(5):408-11. PubMed ID: 316632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [History of 2 cells in T cell lymphomas and leukemias: the cerebriform Lutzner cell in Sézary syndrome and the polylobulated or polypetaloid cell in acute T cell lymphoma/leukemia].
    Lutzner MA
    Hautarzt; 1985 Dec; 36(12):657-62. PubMed ID: 3003011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sézary syndrome. A malignant leukemic reticuloendotheliosis.
    Tedeschi LG; Lansinger DT
    Arch Dermatol; 1965 Sep; 92(3):257-62. PubMed ID: 11851246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.
    Scarisbrick JJ; Hodak E; Bagot M; Stranzenbach R; Stadler R; Ortiz-Romero PL; Papadavid E; Evison F; Knobler R; Quaglino P; Vermeer MH
    Eur J Cancer; 2018 Apr; 93():47-56. PubMed ID: 29477101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.